Abarido, Jilmy R.
HRN: 24-38-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2024
CEFUROXIME 500MG (TAB)
01/14/2024
01/20/2024
PO
1 Tab
Bid
Thickly Msaf
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes